Stockscreener 앱 받기
52.67
2.77%
1.42
시간 외 거래:
53.40
0.73
+1.39%
전일 마감가:
$51.25
열려 있는:
$52.085
하루 거래량:
3.86M
Relative Volume:
1.49
시가총액:
$8.00B
수익:
$3.44B
순이익/손실:
$75.20M
주가수익비율:
100.53
EPS:
0.5239
순현금흐름:
$49.30M
1주 성능:
+10.86%
1개월 성능:
+9.66%
6개월 성능:
+24.08%
1년 성능:
-13.16%
1일 변동 폭
$51.58
$53.47
1주일 범위
$46.85
$53.47
52주 변동 폭
$28.53
$64.64
Bruker Corp Stock (BRKR) Company Profile
명칭
Bruker Corp
전화
978663-3660
주소
40 MANNING RD, BILLERICA, MA
BRKR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
52.67 | 7.79B | 3.44B | 75.20M | 49.30M | 0.5239 |
|
ABT
Abbott Laboratories
|
127.78 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.79 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
366.39 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.31 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.85 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-10 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | 개시 | Goldman | Sell |
| 2025-11-20 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-12-19 | 개시 | Guggenheim | Buy |
| 2024-12-10 | 개시 | UBS | Neutral |
| 2024-12-05 | 업그레이드 | Goldman | Sell → Neutral |
| 2024-10-15 | 개시 | Barclays | Overweight |
| 2024-09-30 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-02-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2022-10-21 | 개시 | UBS | Buy |
| 2022-08-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2021-02-05 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | 개시 | Goldman | Sell |
| 2020-11-16 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | 다운그레이드 | Cleveland Research | Buy → Neutral |
| 2020-04-02 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | 다운그레이드 | Needham | Strong Buy → Hold |
| 2020-03-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | 업그레이드 | Goldman | Sell → Neutral |
| 2019-06-24 | 재확인 | Needham | Strong Buy |
| 2019-06-21 | 재확인 | BofA/Merrill | Neutral |
| 2019-05-30 | 개시 | Wolfe Research | Peer Perform |
| 2019-05-06 | 재확인 | Needham | Strong Buy |
| 2019-05-03 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | 업그레이드 | UBS | Sell → Neutral |
| 2019-04-12 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2019-02-12 | 재확인 | BTIG Research | Buy |
| 2019-01-03 | 개시 | Needham | Strong Buy |
모두보기
Bruker Corp 주식(BRKR)의 최신 뉴스
Bruker Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
Bruker (BRKR) Is Up 7.9% After Winning €35 Million ELI-NP Order In Romania - simplywall.st
Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $53 - 富途牛牛
Why Bruker (BRKR) Stock Is Up Today - Finviz
AbCellera settles patent litigation with Bruker over microfluidic device tech - MSN
Bruker (BRKR) Receives Analyst Rating and Price Target Upgrade f - GuruFocus
Winners And Losers Of Q3: Bruker (NASDAQ:BRKR) Vs The Rest Of The Research Tools & Consumables Stocks - Finviz
Benchtop X-Ray Diffraction Platform | Bruker AXS GmbH | Jul 2023 - Photonics Spectra
Insider Stock Buying Reaches US$1.14m On Bruker - 富途牛牛
Bruker secures $10M in federally funded NMR orders from NYSBC, Delaware, and Northwestern - MSN
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) Competitors - Meyka
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide - AOL.com
Bruker (BRKR) Is Up 6.8% After Settling AbCellera Dispute And Securing Major ELI-NP Contracts - Yahoo Finance
Does Bruker’s 2025 Share Price Slide Present a Hidden Opportunity? - Yahoo Finance
3D Measuring Device | Bruker Alicona | May 2024 - Photonics Spectra
Bruker (BRKR) Valuation Check After €35m ELI-NP Contract Win Drives Fresh Growth Hopes - Yahoo Finance
Bruker Corporation $BRKR Shares Sold by Orion Porfolio Solutions LLC - MarketBeat
Bruker (MIL:1BRKR) EV-to-OCF : 73.37 (As of Dec. 20, 2025) - GuruFocus
Will AbCellera’s (ABCL) Bruker Patent Settlement and Royalties Shift Its Long-Term Revenue Narrative? - simplywall.st
Why Bruker Corporation stock appeals to dividend seekersMarket Trend Review & Weekly Watchlist for Consistent Profits - DonanımHaber
Will Bruker’s (BRKR) AbCellera Settlement and Beacon Royalties Deal Change Its Investment Narrative? - simplywall.st
Will Bruker Corporation stock continue upward momentumMarket Growth Summary & Real-Time Stock Movement Alerts - Улправда
Why Bruker Corporation stock is rated strong buy2025 Buyback Activity & Long-Term Safe Investment Plans - ulpravda.ru
Can Bruker Corporation stock maintain growth trajectoryWeekly Investment Report & Long Hold Capital Preservation Tips - ulpravda.ru
AbCellera stock jumps after settlement with Bruker in patent dispute - Investing.com
Bruker (BRKR) Agrees to $36M Settlement with AbCellera (ABCL) - GuruFocus
AbCellera settles patent dispute with Bruker for $36 million upfront - Investing.com
AbCellera and Bruker Reach Global Settlement of Patent Litigation - Yahoo Finance
Volume Summary: Will Bruker Corporation stock continue upward momentumProfit Target & High Return Stock Watch Alerts - ulpravda.ru
How Recent Analyst Shifts Are Reshaping The Bruker Investment Story - Yahoo Finance
YieldBoost Bruker From 0.4% To 11.2% Using Options - Nasdaq
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $55 to $60 - 富途牛牛
Bruker Corporation $BRKR Shares Sold by Squarepoint Ops LLC - MarketBeat
Reassessing Bruker’s 2025 Valuation After Share Price Rebound And Life Sciences Expansion - simplywall.st
Bruker Is Maintained at Overweight by Barclays - 富途牛牛
Wells Fargo Raises Bruker (BRKR) Price Target to $55 | BRKR Stoc - GuruFocus
Wells Fargo Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $55 - 富途牛牛
Bank of America Raises Bruker (NASDAQ:BRKR) Price Target to $60.00 - MarketBeat
Bruker Is Maintained at Buy by B of A Securities - 富途牛牛
Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $55 - 富途牛牛
BRKR: Analyst Maintains 'Buy' Rating and Raises Price Target to $60 | BRKR Stock News - GuruFocus
Bruker (BRKR): Reassessing Valuation After a Sharp Three-Month Share Price Rebound - simplywall.st
London Co. of Virginia Reduces Holdings in Bruker Corporation $BRKR - MarketBeat
Does Bruker (NASDAQ:BRKR) Have A Healthy Balance Sheet? - 富途牛牛
Goldman Sachs Initiates Sell Rating On Bruker Corporation (BRKR) - Insider Monkey
Stocks making big moves this week: Monolithic Power Systems, Alphabet, Enova, Revolve, and Bruker - Yahoo Finance
Becker Capital Management Inc. Takes $1.76 Million Position in Bruker Corporation $BRKR - MarketBeat
How New European Magnetic Resonance Orders At Bruker (BRKR) Have Changed Its Investment Story - simplywall.st
Bruker (BRKR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
BBH Select Series – Mid Cap Fund Sold Bruker Corporation (BRKR) Due to Policy Uncertainty - Insider Monkey
Bank of Nova Scotia Grows Stock Holdings in Bruker Corporation $BRKR - MarketBeat
Bruker Corp (BRKR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.82%
자본화:
|
볼륨(24시간):